Psychiatry and Neurology, Neurology · Fort Worth, TX
NPI
1770933434
Since 2016
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
7
Hospital affiliations
713 Grainger St
Fort Worth, TX, 76104
Phone (817) 336-3968
Groups this clinician bills Medicare through
Medicare paid, 2024
$250K
11,010 services
Medicare patients, 2024
457
Average age 74
Drug cost, 2024
$3.4M
2,472 prescriptions
Company payments, 2025
$4,236
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leila Bostan Shirin was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,201 times for 21 patients. In total Leila Bostan Shirin billed 11,010 services in 18 codes, and Medicare paid $250K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,201 | 21 | $4.98 | $46K |
| 99215 Office E&M - Established | Office | 570 | 206 | $129.90 | $74K |
| 99223 Hospital E&M - Initial | Facility | 179 | 176 | $133.07 | $24K |
| 99233 Hospital E&M - Subsequent | Facility | 152 | 148 | $91.88 | $14K |
| 95816 Neurologic | Office | 124 | 124 | $301.75 | $37K |
| 95984 Electrical Nerve Conductivity | Office | 120 | 14 | $33.40 | $4,009 |
| 96138 Behavioral Health Services | Office | 106 | 106 | $25.70 | $2,724 |
| 96132 Behavioral Health Services | Office | 106 | 106 | $94.28 | $9,994 |
| 99214 Office E&M - Established | Office | 92 | 60 | $92.10 | $8,474 |
| 99232 Hospital E&M - Subsequent | Facility | 92 | 59 | $61.00 | $5,612 |
| 99205 Office E&M - New | Office | 55 | 55 | $150.48 | $8,277 |
| 95983 Electrical Nerve Conductivity | Office | 50 | 14 | $34.95 | $1,747 |
| 95816 Neurologic | Facility | 49 | 48 | $43.68 | $2,140 |
| 64616 Musculoskeletal | Office | 37 | 17 | $129.22 | $4,781 |
| 95874 Musculoskeletal | Office | 31 | 16 | $59.33 | $1,839 |
By year: 2022 $105K for 1,406 services; 2023 $210K for 4,735 services; 2024 $250K for 11,010 services.
Medicare prescription drug claims, 2024
In 2024, the drug Leila Bostan Shirin prescribed most often to Medicare patients was Rytary (Carbidopa/Levodopa), with 678 prescriptions and refills. In total Leila Bostan Shirin wrote 2,472 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rytary Carbidopa/Levodopa | 678 | 1,520 | 151 | $1.0M |
| Carbidopa-Levodopa Carbidopa/Levodopa | 367 | 886 | 119 | $16K |
| Donepezil Hcl Generic | 151 | 406 | 65 | $2,339 |
| Galantamine Er Galantamine Hbr | 136 | 340 | 51 | $17K |
| Nourianz Istradefylline | 122 | 212 | 28 | $392K |
| Nuplazid Pimavanserin Tartrate | 109 | 149 | 17 | $713K |
| Clonazepam Generic | 90 | 122 | 18 | $1,225 |
| Primidone Generic | 74 | 183 | 22 | $5,085 |
| Memantine Hcl Generic | 66 | 174 | 20 | $2,643 |
| Gocovri Amantadine Hcl | 63 | 87 | 13 | $163K |
| Ingrezza Valbenazine Tosylate | 54 | 60 | Under 11 | $489K |
| Baclofen Generic | 51 | 126 | 21 | $1,750 |
| Sertraline Hcl Generic | 49 | 135 | 22 | $702 |
| Duloxetine Hcl Generic | 44 | 110 | 11 | $1,363 |
| Rasagiline Mesylate Generic | 41 | 112 | 15 | $8,857 |
Brand drugs: 1,130 claims; generic drugs: 1,342 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leila Bostan Shirin $4,236 ($4,236 in general payments such as food, travel and fees) from 29 companies. The largest payer was Abbvie Inc. with $1,021.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 53 | $1,021 |
| Boston Scientific Corporation BSX | 6 | $618 |
| UCB, Inc. UCB.BR | 15 | $341 |
| Biogen, Inc. BIIB | 15 | $328 |
| MDD US Operations, LLC | 12 | $204 |
| Amneal Pharmaceuticals LLC AMRX | 11 | $184 |
| ACADIA Pharmaceuticals Inc ACAD | 9 | $177 |
| Eisai Inc. 4523.T | 6 | $166 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $154 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $129 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.